Mutual of America Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Mutual of America Capital Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.48M	Buy	31,299 +3,173	+11%	+$239K	0.02%	730
2026 Q1	$2.11M	Sell	28,126 -3,333	-11%	-$263K	0.02%	743
2025 Q4	$2.49M	Buy	+31,459	New	+$2.37M	0.03%	711
2015 Q3	–	Sell	-19,000	Closed	-$1.09M	–	1261
2015 Q2	$1.09M	Sell	19,000 -40,167	-68%	-$2.55M	0.02%	978
2015 Q1	$3.77M	Buy	59,167 +3,603	+6%	+$244K	0.08%	361
2014 Q4	$3.43M	Buy	55,564 +877	+2%	+$43.3K	0.08%	405
2014 Q3	$2.12M	Hold	54,687	–	–	0.05%	633
2014 Q2	$1.88M	Sell	54,687 -3,309	-6%	-$104K	0.04%	722
2014 Q1	$2.51M	Buy	57,996 +3,600	+7%	+$175K	0.06%	567
2013 Q4	$2.17M	Buy	54,396 +9,496	+21%	+$338K	0.05%	626
2013 Q3	$1.69M	Buy	+44,900	New	+$1.34M	0.05%	683

Other funds holding IONS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Mutual of America Capital Management's IONS Position: Q2 2026 in Review

Mutual of America Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 11% in Q2 2026, buying an estimated $239K and bringing the position to 31,299 shares worth $2.48M. The position accounts for 0.02% of the portfolio, ranked #730.

Mutual of America Capital Management first reported a position in IONS in Q3 2013 and has held it in 11 quarters since. The position peaked at $3.77M in Q1 2015. 271 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Mutual of America Capital Management held 31,299 shares of Ionis Pharmaceuticals worth $2.48M as of Q2 2026.
Mutual of America Capital Management bought 3,173 Ionis Pharmaceuticals shares in Q2 2026, an estimated $239K.
Ionis Pharmaceuticals made up 0.02% of Mutual of America Capital Management's portfolio in Q2 2026, its #730 holding.
Mutual of America Capital Management first reported a position in Ionis Pharmaceuticals in Q3 2013 and has held it in 11 quarters since.
Mutual of America Capital Management's Ionis Pharmaceuticals position peaked at $3.77M in Q1 2015.
271 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Mutual of America Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.